To synthesize
N1,6-methyladenosine,
N6-methyladenosine (Selleckchem) was dissolved in dry DMF and followed with addition of
iodomethane (Acros Organics; 10:1 molar ratio
iodomethane:
N6-methyladenosine). The mixture was stirred overnight at room temperature. The product was purified by flash chromatography on silica gel (EMD), eluting with methanol and dichloromethane (1:10 to 1:5; ACS or HPLC grade solvents). This resulted in a product yield of 46.3%
N1,6-methyladenosine. Product identity was confirmed by nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HR-MS).
NMR spectra were recorded using a 500-MHz Bruker
DMX-500 instrument at room temperature, and chemical shifts were referenced to the residual solvent peak. Shifts were as follows:
1H NMR (500 MHz, DMSO-
d6) δ 8.11 (s, 1H), 8.04 (s, 1H), 5.76 (d,
J = 5.8 Hz, 1H), 5.15 (s, 1H), 4.43 (t,
J = 5.4 Hz, 1H), 4.15 (m, 2H), 3.92 (d,
J = 3.7 Hz, 1H), 3.63 (dd,
J = 12.0, 3.9 Hz, 1H), 3.56 (m, 2H), 3.50 (s, 3H), 3.45 (d,
J = 6.5 Hz, 1H), 1.23 (s, 3H).
HR-MS data were recorded with Waters
LCT-Premier XE at room temperature. For a predicted mass for
N1,6-methyladenosine, or C
12H
18N
5O
4+, of 296.1353, the mass found was 296.1361.
Grozhik A.V., Olarerin-George A.O., Sindelar M., Li X., Gross S.S, & Jaffrey S.R. (2019). Antibody cross-reactivity accounts for widespread appearance of m1A in 5’UTRs. Nature Communications, 10, 5126.